Neo-Concept International Group Holdings Limited
Get $10 bonus on your first $100 deposit for NCI
Get $10 bonus on your first $100 deposit for NCI
Neo-Concept International Group Holdings Limited (NCI) Stock Competitors & Peer Comparison
See (NCI) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NCI | $0.76 | -8.90% | 3.1M | 2.70 | $0.28 | N/A |
| RL | $348.02 | -1.41% | 21.1B | 23.69 | $14.69 | +1.05% |
| GIL | $54.45 | -2.75% | 8.3B | 21.19 | $2.57 | +1.70% |
| LEVI | $18.91 | -0.47% | 7.5B | 15.01 | $1.26 | +2.91% |
| VFC | $16.87 | -0.30% | 6.6B | 29.60 | $0.57 | +2.13% |
| KTB | $69.01 | -2.67% | 3.8B | 17.04 | $4.05 | +3.04% |
| PVH | $77.11 | +0.72% | 3.7B | 148.29 | $0.52 | +0.19% |
| COLM | $54.45 | -0.26% | 2.9B | 16.81 | $3.24 | +2.20% |
| ZGN | $10.55 | -2.85% | 2.7B | 23.98 | $0.44 | +1.34% |
| FIGS | $14.66 | +0.27% | 2.4B | 77.16 | $0.19 | N/A |
Stock Comparison
NCI vs RL Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, RL has a market cap of 21.1B. Regarding current trading prices, NCI is priced at $0.76, while RL trades at $348.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas RL's P/E ratio is 23.69. In terms of profitability, NCI's ROE is +0.02%, compared to RL's ROE of +0.35%. Regarding short-term risk, NCI is more volatile compared to RL. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check RL's competition here
NCI vs GIL Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, GIL has a market cap of 8.3B. Regarding current trading prices, NCI is priced at $0.76, while GIL trades at $54.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas GIL's P/E ratio is 21.19. In terms of profitability, NCI's ROE is +0.02%, compared to GIL's ROE of +0.20%. Regarding short-term risk, NCI is more volatile compared to GIL. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check GIL's competition here
NCI vs LEVI Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, LEVI has a market cap of 7.5B. Regarding current trading prices, NCI is priced at $0.76, while LEVI trades at $18.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas LEVI's P/E ratio is 15.01. In terms of profitability, NCI's ROE is +0.02%, compared to LEVI's ROE of +0.27%. Regarding short-term risk, NCI is more volatile compared to LEVI. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check LEVI's competition here
NCI vs VFC Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, VFC has a market cap of 6.6B. Regarding current trading prices, NCI is priced at $0.76, while VFC trades at $16.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas VFC's P/E ratio is 29.60. In terms of profitability, NCI's ROE is +0.02%, compared to VFC's ROE of +0.15%. Regarding short-term risk, NCI is more volatile compared to VFC. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check VFC's competition here
NCI vs KTB Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, KTB has a market cap of 3.8B. Regarding current trading prices, NCI is priced at $0.76, while KTB trades at $69.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas KTB's P/E ratio is 17.04. In terms of profitability, NCI's ROE is +0.02%, compared to KTB's ROE of +0.45%. Regarding short-term risk, NCI is more volatile compared to KTB. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check KTB's competition here
NCI vs PVH Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, PVH has a market cap of 3.7B. Regarding current trading prices, NCI is priced at $0.76, while PVH trades at $77.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas PVH's P/E ratio is 148.29. In terms of profitability, NCI's ROE is +0.02%, compared to PVH's ROE of +0.01%. Regarding short-term risk, NCI is more volatile compared to PVH. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check PVH's competition here
NCI vs COLM Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, COLM has a market cap of 2.9B. Regarding current trading prices, NCI is priced at $0.76, while COLM trades at $54.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas COLM's P/E ratio is 16.81. In terms of profitability, NCI's ROE is +0.02%, compared to COLM's ROE of +0.11%. Regarding short-term risk, NCI is more volatile compared to COLM. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check COLM's competition here
NCI vs ZGN Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, ZGN has a market cap of 2.7B. Regarding current trading prices, NCI is priced at $0.76, while ZGN trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas ZGN's P/E ratio is 23.98. In terms of profitability, NCI's ROE is +0.02%, compared to ZGN's ROE of +0.10%. Regarding short-term risk, NCI is more volatile compared to ZGN. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check ZGN's competition here
NCI vs FIGS Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, FIGS has a market cap of 2.4B. Regarding current trading prices, NCI is priced at $0.76, while FIGS trades at $14.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas FIGS's P/E ratio is 77.16. In terms of profitability, NCI's ROE is +0.02%, compared to FIGS's ROE of +0.08%. Regarding short-term risk, NCI is more volatile compared to FIGS. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check FIGS's competition here
NCI vs UAA Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, UAA has a market cap of 2.4B. Regarding current trading prices, NCI is priced at $0.76, while UAA trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas UAA's P/E ratio is -4.61. In terms of profitability, NCI's ROE is +0.02%, compared to UAA's ROE of -0.29%. Regarding short-term risk, NCI is more volatile compared to UAA. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check UAA's competition here
NCI vs UA Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, UA has a market cap of 2.4B. Regarding current trading prices, NCI is priced at $0.76, while UA trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas UA's P/E ratio is -4.51. In terms of profitability, NCI's ROE is +0.02%, compared to UA's ROE of -0.29%. Regarding short-term risk, NCI is more volatile compared to UA. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check UA's competition here
NCI vs HBI Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, HBI has a market cap of 2.3B. Regarding current trading prices, NCI is priced at $0.76, while HBI trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas HBI's P/E ratio is 5.53. In terms of profitability, NCI's ROE is +0.02%, compared to HBI's ROE of +1.91%. Regarding short-term risk, NCI is more volatile compared to HBI. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check HBI's competition here
NCI vs AIN Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, AIN has a market cap of 1.5B. Regarding current trading prices, NCI is priced at $0.76, while AIN trades at $52.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas AIN's P/E ratio is -26.94. In terms of profitability, NCI's ROE is +0.02%, compared to AIN's ROE of -0.07%. Regarding short-term risk, NCI is more volatile compared to AIN. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check AIN's competition here
NCI vs GIII Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, GIII has a market cap of 1.2B. Regarding current trading prices, NCI is priced at $0.76, while GIII trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas GIII's P/E ratio is 18.54. In terms of profitability, NCI's ROE is +0.02%, compared to GIII's ROE of +0.04%. Regarding short-term risk, NCI is more volatile compared to GIII. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check GIII's competition here
NCI vs GOOS Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, GOOS has a market cap of 1B. Regarding current trading prices, NCI is priced at $0.76, while GOOS trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas GOOS's P/E ratio is 65.94. In terms of profitability, NCI's ROE is +0.02%, compared to GOOS's ROE of +0.04%. Regarding short-term risk, NCI is more volatile compared to GOOS. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check GOOS's competition here
NCI vs OXM Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, OXM has a market cap of 584.8M. Regarding current trading prices, NCI is priced at $0.76, while OXM trades at $39.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas OXM's P/E ratio is -21.13. In terms of profitability, NCI's ROE is +0.02%, compared to OXM's ROE of -0.05%. Regarding short-term risk, NCI is more volatile compared to OXM. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check OXM's competition here
NCI vs SGC Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, SGC has a market cap of 163.2M. Regarding current trading prices, NCI is priced at $0.76, while SGC trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas SGC's P/E ratio is 22.59. In terms of profitability, NCI's ROE is +0.02%, compared to SGC's ROE of +0.04%. Regarding short-term risk, NCI is more volatile compared to SGC. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check SGC's competition here
NCI vs LAKE Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, LAKE has a market cap of 83.1M. Regarding current trading prices, NCI is priced at $0.76, while LAKE trades at $8.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas LAKE's P/E ratio is -1.89. In terms of profitability, NCI's ROE is +0.02%, compared to LAKE's ROE of -0.26%. Regarding short-term risk, NCI is more volatile compared to LAKE. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check LAKE's competition here
NCI vs FFFZ Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, FFFZ has a market cap of 68.8M. Regarding current trading prices, NCI is priced at $0.76, while FFFZ trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas FFFZ's P/E ratio is N/A. In terms of profitability, NCI's ROE is +0.02%, compared to FFFZ's ROE of N/A. Regarding short-term risk, NCI is more volatile compared to FFFZ. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check FFFZ's competition here
NCI vs UFI Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, UFI has a market cap of 66.5M. Regarding current trading prices, NCI is priced at $0.76, while UFI trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas UFI's P/E ratio is -2.93. In terms of profitability, NCI's ROE is +0.02%, compared to UFI's ROE of -0.23%. Regarding short-term risk, NCI is more volatile compared to UFI. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check UFI's competition here
NCI vs CULP Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, CULP has a market cap of 41M. Regarding current trading prices, NCI is priced at $0.76, while CULP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas CULP's P/E ratio is -4.05. In terms of profitability, NCI's ROE is +0.02%, compared to CULP's ROE of -0.13%. Regarding short-term risk, NCI is more volatile compared to CULP. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check CULP's competition here
NCI vs JRSH Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, JRSH has a market cap of 38M. Regarding current trading prices, NCI is priced at $0.76, while JRSH trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas JRSH's P/E ratio is 21.36. In terms of profitability, NCI's ROE is +0.02%, compared to JRSH's ROE of +0.03%. Regarding short-term risk, NCI is more volatile compared to JRSH. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check JRSH's competition here
NCI vs VNCE Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, VNCE has a market cap of 31.6M. Regarding current trading prices, NCI is priced at $0.76, while VNCE trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas VNCE's P/E ratio is -1.60. In terms of profitability, NCI's ROE is +0.02%, compared to VNCE's ROE of -0.40%. Regarding short-term risk, NCI is more volatile compared to VNCE. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check VNCE's competition here
NCI vs JL Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, JL has a market cap of 26.5M. Regarding current trading prices, NCI is priced at $0.76, while JL trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas JL's P/E ratio is 10.35. In terms of profitability, NCI's ROE is +0.02%, compared to JL's ROE of +0.31%. Regarding short-term risk, NCI is more volatile compared to JL. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check JL's competition here
NCI vs LLL Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, LLL has a market cap of 10.8M. Regarding current trading prices, NCI is priced at $0.76, while LLL trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas LLL's P/E ratio is -0.10. In terms of profitability, NCI's ROE is +0.02%, compared to LLL's ROE of +0.22%. Regarding short-term risk, NCI is more volatile compared to LLL. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check LLL's competition here
NCI vs PMNT Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, PMNT has a market cap of 8M. Regarding current trading prices, NCI is priced at $0.76, while PMNT trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas PMNT's P/E ratio is -0.34. In terms of profitability, NCI's ROE is +0.02%, compared to PMNT's ROE of -10.56%. Regarding short-term risk, NCI is more volatile compared to PMNT. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check PMNT's competition here
NCI vs XELB Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, XELB has a market cap of 6.5M. Regarding current trading prices, NCI is priced at $0.76, while XELB trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas XELB's P/E ratio is -0.17. In terms of profitability, NCI's ROE is +0.02%, compared to XELB's ROE of -0.86%. Regarding short-term risk, NCI is more volatile compared to XELB. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check XELB's competition here
NCI vs DXYN Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, DXYN has a market cap of 6.1M. Regarding current trading prices, NCI is priced at $0.76, while DXYN trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas DXYN's P/E ratio is -0.86. In terms of profitability, NCI's ROE is +0.02%, compared to DXYN's ROE of -0.60%. Regarding short-term risk, NCI is more volatile compared to DXYN. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check DXYN's competition here
NCI vs JXJT Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, JXJT has a market cap of 4.9M. Regarding current trading prices, NCI is priced at $0.76, while JXJT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas JXJT's P/E ratio is 1.47. In terms of profitability, NCI's ROE is +0.02%, compared to JXJT's ROE of +0.22%. Regarding short-term risk, NCI is more volatile compared to JXJT. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check JXJT's competition here
NCI vs DLA Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, DLA has a market cap of 4.1M. Regarding current trading prices, NCI is priced at $0.76, while DLA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas DLA's P/E ratio is -0.06. In terms of profitability, NCI's ROE is +0.02%, compared to DLA's ROE of -0.20%. Regarding short-term risk, NCI is less volatile compared to DLA. This indicates potentially lower risk in terms of short-term price fluctuations for NCI.Check DLA's competition here
NCI vs EVK Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, EVK has a market cap of 0. Regarding current trading prices, NCI is priced at $0.76, while EVK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas EVK's P/E ratio is N/A. In terms of profitability, NCI's ROE is +0.02%, compared to EVK's ROE of -0.00%. Regarding short-term risk, NCI is less volatile compared to EVK. This indicates potentially lower risk in terms of short-term price fluctuations for NCI.Check EVK's competition here
NCI vs PERY Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, PERY has a market cap of 0. Regarding current trading prices, NCI is priced at $0.76, while PERY trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas PERY's P/E ratio is N/A. In terms of profitability, NCI's ROE is +0.02%, compared to PERY's ROE of +0.15%. Regarding short-term risk, NCI is more volatile compared to PERY. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check PERY's competition here
NCI vs KBSF Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, KBSF has a market cap of 0. Regarding current trading prices, NCI is priced at $0.76, while KBSF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas KBSF's P/E ratio is -1.46. In terms of profitability, NCI's ROE is +0.02%, compared to KBSF's ROE of -0.10%. Regarding short-term risk, NCI is more volatile compared to KBSF. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check KBSF's competition here
NCI vs SQBG Comparison April 2026
NCI plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NCI stands at 3.1M. In comparison, SQBG has a market cap of 0. Regarding current trading prices, NCI is priced at $0.76, while SQBG trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NCI currently has a P/E ratio of 2.70, whereas SQBG's P/E ratio is N/A. In terms of profitability, NCI's ROE is +0.02%, compared to SQBG's ROE of -1.42%. Regarding short-term risk, NCI is more volatile compared to SQBG. This indicates potentially higher risk in terms of short-term price fluctuations for NCI.Check SQBG's competition here